Novomix 30 100 U/ml Penfill
Prescription required
Coupons & Offers
Highlights
composition with strength
Insulin Aspart (30%), Insulin Aspart Protamine (70%)
description
Novomix 30 Penfill is a biphasic insulin aspart formulation combining rapid and intermediate-acting insulin for comprehensive glucose management. It offers strong post-meal control along with basal coverage in diabetes. Inject immediately before meals as directed. Consistent meal timing and blood glucose monitoring help lower hypoglycemia risk and improve overall glycemic balance.
key benefits
Treatment of Diabetes Mellitus
Information
disclaimer
The contents and images displayed on this Platform are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a registered medical practitioner with any questions you may have regarding a medical condition or the use of any product. Do not disregard professional medical advice or delay seeking it because of something you have read on this Platform.We intend to support, not replace, the doctor-patient relationship.
While we make every effort to ensure the information provided is accurate and up-to-date, we strongly recommend reviewing product labels, batch numbers, manufacturing and packaging details, as well as any warnings and usage instructions before using or consuming any product.
customer care details
In case of any issue, contact us
E-mail address: support@zeptonow.com
Seller Name
Geddit Convenience Private Limited
Seller Address
Geddit Convenience Private Limited,Unit 601, Sakti Statesman, 6th floor, Green Glen Layout, No.37/301/34/1, SY.No.34, Ibblur Village, Begur Hobli Bangalore, Karnataka-560103 For Support ReachOut : support+geddit@zeptonow.com
Pharmacy License No.
KA-B62-271728, KA-B62-271729
Country of Origin
Brazil
Manufacturer or Marketer Name
Novo Nordisk India Private Limited
Manufacturer or Marketer Address
Plot No.32, 47-50, EPIP Area, Whitefield, Bangalore - 560 066
Shelf Life
24 months
Expires on or after
November 2026
